Literature DB >> 21166679

Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo.

Anna Moszczynska1, Bryan K Yamamoto.   

Abstract

Methamphetamine (METH) is toxic to dopaminergic (DAergic) terminals in animals and humans. An early event in METH neurotoxicity is an oxidative stress followed by damage to proteins and lipids. The removal of damaged proteins is accomplished by the ubiquitin-proteasome system (UPS) and the impairment of this system can cause neurodegeneration. Whether dysfunction of the UPS contributes to METH toxicity to DAergic terminals has not been determined. The present investigation examined the effects of METH on functions of parkin and proteasome in rat striatal synaptosomes. METH rapidly modified parkin via conjugation with 4-hydroxy-2-nonenal (4-HNE) to decrease parkin levels and decreased the activity of the 26S proteasome while simultaneously increasing chymotrypsin-like activity and 20S proteasome levels. Prior injections of vitamin E diminished METH-induced changes to parkin and the 26S proteasome as well as long-term decreases in DA and its metabolites' concentrations in striatal tissue. These results suggest that METH causes lipid peroxidation-mediated damage to parkin and the 26S proteasome. As the changes in parkin and 26S occur before the sustained deficits in DAergic markers, an early loss of UPS function may be important in mediating the long-term degeneration of striatal DAergic terminals via toxic accumulation of parkin substrates and damaged proteins.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21166679      PMCID: PMC3610410          DOI: 10.1111/j.1471-4159.2010.07147.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  72 in total

Review 1.  Degradation of oxidized proteins by the 20S proteasome.

Authors:  K J Davies
Journal:  Biochimie       Date:  2001 Mar-Apr       Impact factor: 4.079

2.  A proteasomal stress response: pre-treatment with proteasome inhibitors increases proteasome activity and reduces neuronal vulnerability to oxidative injury.

Authors:  Chul-Sang Lee; Lee Y Tee; Timothy Warmke; Anant Vinjamoori; Aili Cai; Anne M Fagan; B Joy Snider
Journal:  J Neurochem       Date:  2004-11       Impact factor: 5.372

Review 3.  Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors.

Authors:  Martin Rechsteiner; Christopher P Hill
Journal:  Trends Cell Biol       Date:  2005-01       Impact factor: 20.808

4.  Recognition and processing of misfolded proteins by PA700, the 19S regulatory complex of the 26S proteasome.

Authors:  Chang-Wei Liu; Elizabeth Strickland; George N Demartino; Philip J Thomas
Journal:  Methods Mol Biol       Date:  2005

5.  Activation of NFkappaB and Ub-proteasome pathway during apoptosis induced by a serum factor is mediated through the upregulation of the 26S proteasome subunits.

Authors:  S Singh; A Khar
Journal:  Apoptosis       Date:  2006-05       Impact factor: 4.677

Review 6.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 7.  Degradation of oxidized proteins in mammalian cells.

Authors:  T Grune; T Reinheckel; K J Davies
Journal:  FASEB J       Date:  1997-06       Impact factor: 5.191

Review 8.  Potential new insights into the molecular mechanisms of methamphetamine-induced neurodegeneration.

Authors:  M Z Wrona; Z Yang; F Zhang; G Dryhurst
Journal:  NIDA Res Monogr       Date:  1997

9.  Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine.

Authors:  Evan L Riddle; Matthew K Topham; John W Haycock; Glen R Hanson; Annette E Fleckenstein
Journal:  Eur J Pharmacol       Date:  2002-08-02       Impact factor: 4.432

10.  Changes in Activity and Kinetic Properties of the Proteasome in Different Rat Organs during Development and Maturation.

Authors:  A Petersen; A Honarvar; M Zetterberg
Journal:  Curr Gerontol Geriatr Res       Date:  2010-03-31
View more
  31 in total

1.  Methamphetamine-induced oxidation of proteins and alterations in protein processing.

Authors:  Bryan K Yamamoto; Fu-Chen Yang
Journal:  Neuropsychopharmacology       Date:  2012-01       Impact factor: 7.853

Review 2.  HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.

Authors:  Peter S Silverstein; Ankit Shah; James Weemhoff; Santosh Kumar; D P Singh; Anil Kumar
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

3.  Self-administration of methamphetamine alters gut biomarkers of toxicity.

Authors:  Amanda Flack; Amanda L Persons; Sharanya M Kousik; T Celeste Napier; Anna Moszczynska
Journal:  Eur J Neurosci       Date:  2017-08       Impact factor: 3.386

Review 4.  Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review.

Authors:  Eun-Joo Shin; Hai-Quyen Tran; Phuong-Tram Nguyen; Ji Hoon Jeong; Seung-Yeol Nah; Choon-Gon Jang; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Res       Date:  2017-06-07       Impact factor: 3.996

5.  Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells.

Authors:  M Lin; P Chandramani-Shivalingappa; H Jin; A Ghosh; V Anantharam; S Ali; A G Kanthasamy; A Kanthasamy
Journal:  Neuroscience       Date:  2012-03-14       Impact factor: 3.590

6.  Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration.

Authors:  Xiaosha Pang; Jun Panee; Xiangqian Liu; Marla J Berry; Sulie L Chang; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-02       Impact factor: 4.147

7.  Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice.

Authors:  B Butler; J Gamble-George; P Prins; A North; J T Clarke; H Khoshbouei
Journal:  J Addict Prev       Date:  2014

8.  Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.

Authors:  Bin Liu; Roberta Traini; Bryan Killinger; Bernard Schneider; Anna Moszczynska
Journal:  Exp Neurol       Date:  2013-01-09       Impact factor: 5.330

9.  L-Ascorbate Protects Against Methamphetamine-Induced Neurotoxicity of Cortical Cells via Inhibiting Oxidative Stress, Autophagy, and Apoptosis.

Authors:  Ya-Ni Huang; Ling-Yu Yang; Jing-Ya Wang; Chien-Cheng Lai; Chien-Tsai Chiu; Jia-Yi Wang
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

Review 10.  Disease-Toxicant Interactions in Parkinson's Disease Neuropathology.

Authors:  Gunnar F Kwakye; Rachael A McMinimy; Michael Aschner
Journal:  Neurochem Res       Date:  2016-09-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.